ImmuCell Corporation Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
ImmuCell Corporation (ICCC) reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 57.00% for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2018-05-14
- ImmuCell Corporation fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2018-03-31 was 57.00%, a 8.06% decline year-over-year.
- ImmuCell Corporation fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2017-09-30 was 61.00%.
- ImmuCell Corporation fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2017-06-30 was 61.00%.
- ImmuCell Corporation fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 62.00%.
- ImmuCell Corporation fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2016 was 63.00%, a 34.04% increase from fiscal 2015.
- ImmuCell Corporation fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2015 was 47.00%.
- ImmuCell Corporation fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2013 was 49.00%, a 0.62% increase from fiscal 2012.
- ImmuCell Corporation fair value assumptions, expected volatility rate (deprecated 2018-01-31) for fiscal 2012 was 48.70%, a 2.31% increase from fiscal 2011.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | 57.00% 10-Q · filed 2018-05-14 | |||
| 2017-12-31 | 61.00% 10-Q · filed 2018-05-14 | |||
| 2017-09-30 | 61.00% 10-Q · filed 2017-11-13 | 61.00% 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | 61.00% 10-Q · filed 2017-08-14 | 62.00% 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | 62.00% 10-Q · filed 2017-05-11 | |||
| 2016-12-31 | 63.00% 10-K · filed 2018-03-29 | |||
| 2016-09-30 | 63.00% 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | 47.00% 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | 47.00% 10-K · filed 2017-03-30 | |||
| 2014-12-31 | 49.00% 10-Q · filed 2016-08-11 | |||
| 2013-12-31 | 49.00% 10-K · filed 2015-03-26 | |||
| 2012-12-31 | 48.70% 10-K · filed 2015-03-26 | |||
| 2011-12-31 | 47.60% 10-K · filed 2014-03-26 | |||
| 2010-12-31 | 44.20% 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |